Isolated nail psoriasis may be a sign of psoriatic arthritis

Published Date: 02 Mar 2023

In a review of 87 patients, the authors recorded the clinical and histological characteristics of patients with nail psoriasis.

Read Full News

Latest News

Tumor Biomarker Improves Surveillance of MCC Recurrences

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Candida auris Infections Persist, CDC Report Shows

Clinical and screening cases of C auris doubled between 2022 and 2024.

Patient Engagement With Dermatology Visit Notes Remains Low

Patient engagement with dermatology notes in the electronic patient portal varies by language, race, ethnicity, and clinician factors, study shows.

The Newest Frontier for GLP-1s: Clearing Skin Disease

Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.

Strange Asymptomatic Rash Affects Young Man With Obesity for 2 Years

Diagnosis implicates high triglycerides as a contributor

Ambulatory Surgery May Be an Option for Troublesome HS

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Todays Updates

AI-Driven Biomarker Predicts Prostate Cancer Outcomes

The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.

Community Oncology Well Suited for Advanced Cancer Patients

Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.

Latest News

Circulating tumor DNA detects Merkel cell carcinoma recurrence more accurately than Merkel cell polyomavirus antibodies, study finds.

Clinical and screening cases of C auris doubled between 2022 and 2024.

Patient engagement with dermatology notes in the electronic patient portal varies by language, race, ethnicity, and clinician factors, study shows.

Beyond weight loss, new research suggests these blockbuster drugs may target skin inflammation directly.

Diagnosis implicates high triglycerides as a contributor

A wave of recently approved therapies has improved options for the control of hidradenitis suppurativa, but surgery remains a possible option for faster clinical benefit.

News All Time

Pediatric Hereditary Angioedema Treatment Options Growing

From scant data, the armamentarium is expanding, with an increasing evidence base

The Truth About 'Life-Changing Sunburns,' According to a Dermatologist

Can one severe sunburn have serious consequences?

PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy

Prospective clinical trials needed to validate the findings

Volixibat Soothed the Itch in Primary Sclerosing Cholangitis

IBATS inhibitor led to improvement in cholestatic pruritus

Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

Adjuvant approach will need confirmation from ongoing phase III trial, says expert

Trump's Hair-Loss Drug; Bringing Americans With Ebola to U.S.; Widespread ACA Fraud?

Health news and commentary gathered by MedPage Today staff

Novel Lupus Drugs Continue to Shine in Extended Early Data

For one of the two, the benefits continue long after treatment stops

How Much Prednisone Is Too Much in Treating Rheum Effects From Cancer Therapies?

French study posits an answer

What Is Causing This Woman's Swollen Chin?

A long and challenging diagnostic path with twists and turns

FDA OKs First New Sunscreen Ingredient in a Quarter Century

Bemotrizinol blocks UVA and UVB and has been available in Europe since 1999

Is Microdosing Accutane Safe? Dermatologist Weighs In

Patients take the medication less frequently to reduce side effects while gleaning benefits

New Type of Maggots Cleared by FDA as Medical Treatment

Non-antibiotic approach can help deal with non-healing necrotic skin and soft tissue wounds

FDA Expands Risankizumab Label in Psoriatic Disease

IL-23 inhibitor lands indications for kids 6 years and up

CAR T-Cell Therapy for Skin Diseases Near Approval

CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

MCC Linked to Higher Mortality, Healthcare Use

Patients with Merkel cell carcinoma had higher mortality, more hospitalizations, and a greater comorbidity burden than matched patients without the disease and several other cancer cohorts in a study.

Eczema and the Topical Steroid Withdrawal Controversy

Topical steroid withdrawal is a controversial topic. What matters is treating patients with compassion and supporting them in their decision to stop treatment.

Recommended News For You

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

High weight and obesity are associated with poor outcomes in leukemia treatment.

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Report reveals lung cancer is the leading cause of cancer deaths in Florida

Recommended Articles For You

The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025 

Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained 

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision 

Engineered Red Blood Cell Therapeutics: Emerging Applications 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

EVP Beats Cisplatin for Resectable MIBC

2.

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

5.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

1.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

2.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

3.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

4.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

5.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part X

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot